You React to Chemicals Others Don't. Here's the Biological Reason.

GSTM1 encodes an enzyme that binds glutathione to environmental toxins, heavy metals, and carcinogens, making them water-soluble so your body can eliminate them through bile and urine. This is one of your primary defense mechanisms against chemical exposures.

Roughly 50% of people carry a GSTM1 null genotype, meaning the gene is completely deleted and the enzyme is not produced at all. Without this enzyme, you lose an entire pathway for conjugating and clearing toxins. This deletion reduces your capacity to eliminate benzene, pesticides, aromatic hydrocarbons, and heavy metals by up to 100%.

If you carry this variant, you experience faster toxic accumulation from environmental exposures. Chemical odors trigger symptoms faster. Mold-contaminated spaces cause more severe immune reactions. Heavy metal burden builds up more quickly. You need exogenous support for what your body cannot do on its own.

GSTP1 encodes an enzyme that conjugates glutathione to electrophiles,charged molecules and oxidative stress byproducts created when your cells are exposed to toxins, inflammation, or radiation. It is your primary defense against reactive molecules that damage DNA and proteins.

The Val allele at position 105 is carried by approximately 35-40% of people and reduces GSTP1 enzyme activity by 20-40%. This means fewer of the harmful reactive molecules get neutralized, and oxidative damage accumulates faster inside your cells.

You notice this as chemical sensitivity that gets worse under stress. Your immune system is hyperactive. You experience more fatigue after chemical exposures. Your recovery time is slower. Your joints ache more. Your brain fog is more pronounced. The problem is that your cells are drowning in oxidative stress that you cannot efficiently clear.

CYP1A2 is a Phase I detoxification enzyme that transforms environmental chemicals and airborne pollutants into intermediate metabolites that are then conjugated by your Phase II enzymes (like GSTM1 and GSTP1). It is the first line of defense against inhaled toxins, industrial chemicals, and polycyclic aromatic hydrocarbons.

Certain variants of CYP1A2 either increase or decrease its activity depending on the variant. If you carry variants that reduce CYP1A2 function, you have slower initial processing of environmental chemicals. This means toxic intermediates accumulate in your tissues, and your Phase II enzymes are overwhelmed trying to keep up with the burden.

You notice this as immediate reactions to strong chemical smells, new furniture off-gassing, paint fumes, perfumes, and air pollution. Your symptoms start quickly and last longer than they should. You feel worse in urban areas or around traffic.

MTHFR converts folate into the active methylated form (5-methyltetrahydrofolate) that your cells use to produce glutathione, the master antioxidant and the primary conjugation molecule your detoxification enzymes depend on. Without adequate MTHFR function, you cannot produce enough glutathione to match your toxic burden.

The C677T variant, carried by approximately 40% of people in European ancestry populations, reduces MTHFR enzyme efficiency by 35-50%. This means your glutathione production is compromised, and you lose capacity across all of Phase II detoxification,exactly when you need it most.

You feel this as a compounding effect. Chemical sensitivities get worse when you are stressed or sleep-deprived, because both of these conditions increase your need for glutathione. You recover slowly from exposures. Your detox symptoms persist longer. You may also experience heavier menstrual cycles, higher homocysteine, and increased joint inflammation.

SOD2 encodes a mitochondrial antioxidant enzyme that neutralizes free radicals generated inside the powerhouses of your cells. When your mitochondria are exposed to heavy metals, persistent organic pollutants, or oxidative stress, SOD2 is your primary defense against damage. Without it, your mitochondria deteriorate and your energy production collapses.

The Val16Ala variant, present in approximately 40% of people with European ancestry, reduces SOD2 enzyme efficiency and mitochondrial antioxidant capacity. This means oxidative stress accumulates faster in your mitochondria, especially when you are exposed to environmental toxins or mold.

You experience this as fatigue that does not improve with rest. Chemical exposures drain your energy for days afterward. You have less stamina than you should. Your recovery from illness is slow. You may notice that heavy metals (like mercury from old dental fillings or lead from old paint) cause especially severe fatigue and brain fog.

NQO1 encodes an enzyme that detoxifies quinones and benzene,two of the most common and toxic industrial chemicals you encounter. Benzene is in gasoline fumes, car exhaust, and cigarette smoke. Quinones accumulate in oxidative stress and from environmental exposures. NQO1 is your specific defense against these.

The Pro187Ser null variant, carried by 4-20% of people depending on ancestry, completely eliminates NQO1 function. If you carry this variant, you cannot effectively detoxify benzene or quinones. This means your exposure risk to these specific toxins is dramatically higher, and your body cannot clear them once they enter.

You notice this as extreme sensitivity to gasoline fumes, car exhaust, and smoke. You cannot tolerate being around traffic. You develop headaches and nausea from benzene exposures that others barely detect. Your chemical sensitivity may be worse in urban areas or around smokers.